Cart
sales@molnova.com
(3R,4R)-A2-32-01
CAS No. 1359752-95-6
(3R,4R)-A2-32-01( —— )
Catalog No. M32751 CAS No. 1359752-95-6
(3R,4R)-A2-32-01 is the (R,R)-enantiomer of A2-32-01 and has potential antibacterial activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 225 | In Stock |
|
| 5MG | 424 | In Stock |
|
| 25MG | 1316 | In Stock |
|
| 50MG | 1711 | In Stock |
|
| 100MG | 2250 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(3R,4R)-A2-32-01
-
NoteResearch use only, not for human use.
-
Brief Description(3R,4R)-A2-32-01 is the (R,R)-enantiomer of A2-32-01 and has potential antibacterial activity.
-
Description(3R,4R)-A2-32-01 (compound 24(R,R)), the (R,R)-enantiomer of A2-32-01, is a Staphylococcus aureus caseinolytic protease (SaClpP) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1359752-95-6
-
Formula Weight301.42
-
Molecular FormulaC19H27NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 200 mg/mL (663.53 mM; Ultrasonic )
-
SMILESC(CCCCCCC=C)[C@@H]1[C@@H](CCC=2C=CC=NC2)OC1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Malte Gersch, et al. The mechanism of caseinolytic protease (ClpP) inhibition. Angew Chem Int Ed Engl. 2013 Mar 4;52(10):3009-14.?
molnova catalog
related products
-
Gatifloxacin hydroch...
A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
-
Antibacterial agent ...
Antibacterial Agent 125 exhibits potent antimicrobial activity against clinically relevant Gram-positive pathogens, displaying Minimum Inhibitory Concentration (MIC) 50 values ranging from 0.25 to 8 μM. It is suitable for researching antimicrobial resistance.
-
VB-82252
VB-82252 is a highly potent, orally active inhibitor of C. difficile toxins TcdA and TcdB, potently inhibits UDP glucose hydrolysis activity of TcdB (IC50=32 nM).
